Children and COVID-19 Research Library

The COVID-19 pandemic has had a devastating impact on multiple aspects of healthcare, but has also triggered new ways of working, stimulated novel approaches in clinical research and reinforced the value of previous innovations. Conect4children (c4c, www.conect4children.org) is a large collaborative European network to facilitate the development of new medicines for paediatric populations, and is made up of 35 academic and 10 industry partners from 20 European countries, more than 50 third parties, and around 500 affiliated partners. This study summarises aspects of clinical research in paediatrics stimulated and reinforced by COVID-19 that the Conect4children group recommends regulators, sponsors, and investigators retain for the future, to enhance the efficiency, reduce the cost and burden of medicines and non-interventional studies, and deliver research-equity.

Many public institutions and settings have taken action to limit exposure to and slow the spread of the novel coronavirus (COVID-19). This paper sought to characterize the impact of stay-at-home orders on the study of cerebral autoregulation and its association with developmental delays in infants with congenital heart disease compared with healthy controls.

The severe acute respiratory syndrome coronavirus disease 2019 (COVID-19) outbreak rapidly became a worldwide pandemic in early 2020. In Australia, government-mandated restrictions on non-essential face-to-face contact in the healthcare setting have been crucial for limiting opportunities for COVID-19 transmission, but they have severely limited, and even halted, many research activities. This institute’s research practices in the vulnerable populations of pregnant women and young infants needed to adapt in order to continue without exposing participants, or staff, to an increased risk of exposure to COVID-19. Here, are discuss pre-and-post COVID-19 methods for conducting research regarding nutrition during pregnancy, infancy, and early childhood.

The COVID-19 pandemic has already had widespread effects on healthcare and health-related research worldwide. Early phase responses to the pandemic included restriction of clinical care and research to essential, time-sensitive and COVID-related activities in many institutions. With the re-introduction of clinical services, a number of strategies were imposed to minimize viral transmission to patients and healthcare personnel, such as strict limits on visitors/caregivers in pediatric inpatient facilities, which may have ethical implications on family-centered care. This study investigates consent rates for a clinical research study before and after implementation of a one-visitor policy at our children’s hospital.

Children and young people’s participation in decision-making has substantially increased in the last 3 decades; although, their participation in research has been more problematic due to traditional views that exclude them from the realm of knowledge generation. This article critically reflects on the way that 12 children and young people engaged as co-researchers in an intergenerational research project that explored the perspectives of children and young people during the COVID-19 outbreak. Drawing upon the experiences of these child researchers, the author discusses the methodological and ethical complexities of their engagement—which is already a disputed topic—in the context of the global health crisis characterized by lockdowns, isolation, and social distancing.

The emergence of coronavirus disease 2019 (COVID-19) prompted a surge in research activity. Funding bodies swiftly allocated resources to establish research infrastructures and partnerships to study the novel virus. The scientific community realigned existing research and launched new studies to define the clinical course of COVID-19 and identify therapeutic candidates. Overall, comparatively fewer studies were initiated in children relative to adults, in part due to the lower prevalence and disease morbidity recorded in pediatric populations. However, characterizing the disease in pediatric patients is critical to elucidate transmission dynamics, inform public health measures, and generate evidence on best practices for clinical care and therapeutic interventions. The life-threatening multisystem inflammatory syndrome further underscores the need for natural history studies and drug development in pediatric populations.

This commentary aims to examine the crucial role of dissemination and implementation (D&I) science—the study of methods to promote adoption and integration of evidence-based research in real-world policy or practice—to improve public health post–COVID-19. D&I science was created for this very situation, in which scientific knowledge is greatly needed but only if it holds practical relevance for the policy, environmental, and organizational systems that advance health. The paper discusses the application of D&I science to rapid evaluations of federal child nutrition assistance programs deployed during the COVID-19 pandemic.

The COVID-19 pandemic has resulted in unprecedented research worldwide. The impact on research in progress at the time of the pandemic, the importance and challenges of real-time pandemic research, and the importance of a pediatrician-scientist workforce are all highlighted by this epic pandemic. As we navigate through and beyond this pandemic, which will have a long-lasting impact on our world, including research and the biomedical research enterprise, it is important to recognize and address opportunities and strategies for, and challenges of research and strengthening the pediatrician-scientist workforce.